14th Mar 2007 07:01
Tepnel Life Sciences PLC14 March 2007 Tepnel Life Sciences plc ('Tepnel' or 'the Company') Notice of 2006 Preliminary Results Manchester, UK, 14th March 2007 Tepnel Life Sciences PLC (AIM: TED), theinternational Molecular Diagnostics and Research Products & Services group, willannounce its preliminary results for the year ended 31st December 2006 onThursday 15th March 2007. The results announcement will be released at 7.00am GMT. - Ends- For Further Information: Tepnel Life Sciences plcBen Matzilevich, CEOCarol SmithTel: 0161 946 2200 Capital MS&LMary Clark or Halina KukulaTel: +44 20 7307 5330Email: [email protected] Notes to Editors About Tepnel Life Sciences plc Tepnel Life Sciences (AIM:TED) is a UK-based international life sciencesproducts and services group with two divisions, Molecular Diagnostics andResearch Products & Services. The Company has laboratories, manufacturing andoperations in the USA, UK and France with 195 employees. TLS provides testkits, reagents and services to two highly synergistic markets, these beingMolecular Diagnostics and Biomedical Research. The company's strategy has beento identify high growth niche opportunities within these multi-billion poundmarkets. TLS focuses on these niche opportunities with internally developedproducts, patents, expertise and know-how as well as strategic acquisitions, todevelop a leadership position within these defined market segments. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TED.L